The risk of adverse obstetric outcomes is elevated in women who conceive while using an intrauterine device (IUD), especially in women who retain the device throughout pregnancy, according to a study in the October issue of the American Journal of Obstetrics & Gynecology.
Users at conception have a higher risk of preterm delivery and chorioamnionitis than nonusers
THURSDAY, Oct. 1 (HealthDay News)-The risk of adverse obstetric outcomes is elevated in women who conceive while using an intrauterine device (IUD), especially in women who retain the device throughout pregnancy, according to a study in the October issue of the
American Journal of Obstetrics & Gynecology.
Hadas Ganer, of Ben Gurion University of the Negev in Be'er-Sheva, Israel, and colleagues compared pregnancy outcomes in 98 women with a retained IUD, 194 women with an IUD removed in early pregnancy, and 141,191 women without an IUD.
The researchers found that the rate of preterm delivery was significantly higher in the retained-IUD and removed-IUD groups (18.4 and 14.4 percent, respectively) than in the no-IUD group (7.3 percent). They also found that the rate of chorioamnionitis was significantly higher in the two IUD groups (7.1 and 4.1 percent, respectively) than in the no-IUD group (0.7 percent).
"Women conceiving with an IUD should be informed regarding these outcomes because IUD removal reduces the risk for adverse obstetric outcomes, but does not eliminate it," the authors conclude. "Careful surveillance of high-risk pregnancies is warranted, as well as neonatal surveillance in the case of preterm and chorioamnionitic deliveries."
Abstract
Study highlights need for interventions to prevent postpartum smoking relapse
January 21st 2025Smoking cessation during pregnancy not only reduces pregnancy complications but also lowers the risk of relapse and new smoking initiation in the first postpartum year, according to a recent study.
Read More
USPSTF recommends osteoporosis screening for senior women to prevent fractures
January 20th 2025The US Preventive Services Task Force emphasizes screening for osteoporosis in women aged 65 years and older and at-risk postmenopausal women aged under 65 years, citing moderate benefits in fracture prevention.
Read More